54 completed. 54 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 54 | Completed 54 |
Follow Ezetimibe: new trials by email Literature Review of Ezetimibe trials Research Report on Ezetimibe
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol Rosuvastatin + Ezetimibe, Bempedoic Acid + Ezetimibe, Rosuvastatin + Ezetimibe + Bempedoic Acid - Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol | Phase 4 | Completed | Bahria University | 126 | 2026-01-01 | 2026-10-20 |
| Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI Evolocumab 140 MG/ML, Rosuvastatin 5mg, Ezetimibe 10mg - Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Phase 4 | Completed | Yonsei University | 108 | 2022-12-01 | 2025-03-13 |
| Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease Rosuvastatin and Ezetimibe, Rosuvastatin - Atheroscleroses, Coronary | Phase 4 | Completed | Korea University Anam Hospital | 582 | 2021-08-11 | 2023-08-08 |
| A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients Mavyret - Hepatitis C, Kidney Transplant; Complications | Phase 4 | Completed | Mayo Clinic | 227 | 2020-09-10 | 2026-10-29 |
| CHOlesterol Lowering and Residual Risk in Type 2 Diabetes Statin, PCSK9 inhibitor, Ezetimibe 10mg - Type 2 Diabetes | Phase 4 | Completed | NYU Langone Health | 151 | 2020-08-12 | 2024-10-17 |
| Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg), Suvast tablet 10 mg (Rosuvastatin 10 mg) - Endocrine System Diseases, Nutritional and Metabolic Diseases | Phase 4 | Completed | Seoul National University Hospital | 146 | 2020-01-03 | 2025-08-14 |
| Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets Ezetimibe/Rosuvastatin, Candesartan cilexetil/Amlodipine besylate, Candesartan cilexetil - Hypertension, Hyperlipidemia | Phase 4 | Completed | HK inno.N Corporation | 127 | 2018-07-05 | 2022-05-10 |
| Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome high-dose rosuvastatin, low-dose rosuvastatin plus ezetimibe - Acute Coronary Syndrome, Carotid Atherosclerotic Plaque With Inflammation | Phase 4 | Completed | Yuhan Corporation | 50 | 2017-06-29 | 2019-08-16 |
| Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia Alirocumab SAR236553, Atorvastatin, Rosuvastatin - Hypercholesterolemia, Acute Coronary Syndrome | Phase 4 | Completed | Sanofi | 206 | 2016-11-15 | 2019-09-09 |
| Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) Alirocumab, Statins, Ezetimibe - Dyslipidemia | Phase 4 | Completed | Sanofi | 413 | 2016-03-15 | 2018-05-01 |
| Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe Rosuvastatin and Ezetimibe morning or evening administration - Hypercholesterolemia | Phase 4 | Completed | Collegium Medicum w Bydgoszczy | 83 | 2016-03-01 | 2021-02-02 |
| Randomized Trial Comparing Colesevelam vs. Ezetimibe Colesevelam, Ezetimibe - Type 2 Diabetes Mellitus | Phase 4 | Completed | LMC Diabetes & Endocrinology Ltd. | 200 | 2016-01-11 | 2019-11-26 |
| Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels Ezetimibe, Cholecalciferol, Placebo - Vitamin D Deficiency | Phase 4 | Completed | Federal University of Rio Grande do Sul | 52 | 2014-10-01 | 2015-04-09 |
| The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients Ezetimibe - Dyslipidemia, Transplants | Phase 4 | Completed | University Medical Centre Ljubljana | 80 | 2014-04-01 | 2016-05-17 |
| A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541) Ezetimibe, Placebo - Hypercholesterolemia | Phase 4 | Completed | Organon and Co | 152 | 2012-07-02 | 2024-05-24 |
| Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction. Ezetimibe, Placebo - ST-Segment Elevation Myocardial Infarction | Phase 4 | Completed | Odense University Hospital | 87 | 2011-06-01 | 2014-09-03 |
| Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound Combination therapy with Lipitor [Atorvastatin] and Zetia [Ezetimibe], Lipitor (Atorvastatin) monotherapy - Hypercholesterolemia, Coronary Artery Disease | Phase 4 | Completed | Kumamoto University | 245 | 2010-01-01 | 2015-04-01 |
| Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome Zotalolimus Eluting Stent, Everolimus eluting stent, Ezetimibe 10mg & Simvastatin 40mg - Acute Coronary Syndrome | Phase 4 | Completed | Yonsei University | 160 | 2009-11-01 | 2014-02-05 |
| Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL) SIMVASTATIN 40 mg, SIMVASTATIN/EZETIMIBE 10/10 mg - Hypercholesterolemia | Phase 4 | Completed | University of Ioannina | 100 | 2009-06-01 | 2011-08-19 |
| The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study Simvastatin, Simvastatin/Ezetimibe - Metabolic Syndrome | Phase 4 | Completed | dr.Frank L.J. Visseren | 100 | 2009-04-01 | 2013-01-09 |
Showing 20 of 54. Sign in to see all of them.
Hypercholesterolemia (25) · Dyslipidemias (8) · Atherosclerosis (7) · Coronary Artery Disease (6) · Diabetes Mellitus, Type 2 (6) · Coronary Disease (5) · Hyperlipidemias (5) · Acute Coronary Syndrome (4) · Cardiovascular Diseases (4) · Diabetes Mellitus (4) · Metabolic Syndrome (3) · Hypertension (2) · Lipid Metabolism Disorders (2) · Atrial Fibrillation (1) · Cerebral Palsy (1)
Organon and Co (14) · Baylor College of Medicine (2) · Sanofi (2) · Yonsei University (2) · Bahria University (1) · Collegium Medicum w Bydgoszczy (1) · Daiichi Sankyo (1) · Federal University of Rio Grande do Sul (1) · Federico II University (1) · HK inno.N Corporation (1) · Hotel Dieu de France Hospital (1) · Karolinska Institutet (1) · Korea University Anam Hospital (1) · Kos Pharmaceuticals (1) · Kumamoto University (1)
United States (9) · South Korea (6) · Germany (4) · Brazil (2) · Israel (2) · Italy (2) · Japan (2) · Lebanon (2) · Netherlands (2) · Sweden (2) · Switzerland (2) · United Kingdom (2) · Australia (1) · Austria (1) · Canada (1)
Ana Carolina M Gagliardi, nutritionist (1) · Bashar A Aqel (1) · Christie Ballantyne, M.D. (1) · Christie M. Ballantyne, MD (1) · Chu-Huang Chen, M.D., Ph.D. (1) · Colin Baigent, FRCP, FFPH (1) · Fatima Khatoon, MBBS (1) · Frank LJ Visseren, MD PhD (1) · Gabriele Riccardi, Prof (1) · Gheorghe AM Pop, MD PhD (1) · Gregor Mlinsek, MD, PhD (1) · Harpreet Bajaj, MD (1)
PMID 38018702, PMID 16749654, PMID 16893434, PMID 17407633, PMID 18545068, PMID 18765432, PMID 19075102, PMID 20067513, PMID 20525999, PMID 20663203, PMID 21122660, PMID 21227624, PMID 21271793, PMID 21663949, PMID 22115011, PMID 22291820, PMID 22621316, PMID 22700717, PMID 23013513, PMID 23544125, PMID 23809138, PMID 24023786, PMID 24075764, PMID 24267254, PMID 24503114, PMID 24653510, PMID 24662777, PMID 24720535, PMID 25929253, PMID 26208795, PMID 26227186, PMID 26385817, PMID 27318866, PMID 28028192, PMID 28460629, PMID 28545518, PMID 28697767, PMID 28780579, PMID 29436756, PMID 29606415, PMID 29925472, PMID 31005271, PMID 31434809, PMID 31662874, PMID 31706300, PMID 32035487, PMID 33078867, PMID 41560483, PMID 42396798
2004 (1), 2008 (1), 2015 (1), R01HL075824 (1)